| July 29, 2010 |
Ontario's Minister Goodyear Announces $45 Million Investment in Innovation and Job Creation Through NRC-IRAP at Sernova Corp. |
| July 12, 2010 |
Sernova Announces Positive Results of its Proprietary Cell Pouch System(tm) in Preclinical Diabetes Model |
| June 08, 2010 |
Sernova Completes Second Closing Of Private Placement |
| May 28, 2010 |
Sernova Presents Cell Pouch System Preclinical Results At The American Society Of Internal Artificial Organs |
| May 26, 2010 |
Appointment Of Stephen Nagler To The Sernova Business Advisory Board |
| April 29, 2010 |
Sernova Announces $1.2M Private Placement And $400,000 First Closing |
| April 07, 2010 |
Sernova To Present At Biofinance Canada Conference |
| March 16, 2010 |
Sernova Announces Interim Results from Key Preclincal Study With its Proprietary Cell Pouch System(tm) |
| March 02, 2010 |
Sernova Advances Cell Pouch System(tm) Into Non-Human Primate Studies |
| January 25, 2010 |
Sernova To Present At Biopartnering North America Conference |
| December 31, 2009 |
Sernova Completes $500,000 Private Placement |
| November 10, 2009 |
Appointment Of Hans Mader To The Sernova Business Advisory Board |
| November 02, 2009 |
Sernova Closes First Tranche Of Private Placement And Announces Appointment Of Dr. Annemarie Moseley To Board Of Directors |
| October 20, 2009 |
Sernova's Cell Pouch System(tm) and Sertolin(tm) Preclinical Efficacy Presented at Leading International Islet Transplant Conference |
| October 07, 2009 |
Sernova Corp. Announces Private Placement - Company To Present At Biocontact Conference In Quebec City |
| September 30, 2009 |
Sernova To Present Research Results At Leading International Islet Transplant Conference |
| August 31, 2009 |
Notice of Allowance Issued for Key Patent for Sernova's Sertoli Cell Platform |
| August 06, 2009 |
Appointment of Dr. Annemarie Moseley to the Sernova Business Advisory Board |
| July 20, 2009 |
Sernova Announces Financial Contributions from the National Research Council to Support Development of Human Implantation Device |
| June 29, 2009 |
Appointment of Dr. Philip M. Toleikis to the Sernova Board of Directors |
| June 01, 2009 |
Closing Of $420,000 Private Placement |
| April 28, 2009 |
New Strategic Plan |
| January 21, 2009 |
Sernova Corp.: Resignation of Justin Leushner as President Board of Directors Initiates Internal Review |
| October 15, 2008 |
Jeffrey Bacha Appointed to Sernova Board of Directors - Grant of Stock Options |
| August 13, 2008 |
Sernova Corp.'s Diabetes Technology Featured at International Congress of the Transplantation Society and on CTV National News |
| July 30, 2008 |
Appointment of New Officers |
| May 06, 2008 |
Sernova Concludes Successful Pre-IND Meeting with FDA |
| April 16, 2008 |
Sernova Corp. Annual Meeting |
| March 25, 2008 |
Islet Cell Pioneer Appointed to Help Advance Sertolin Diabetes Therapy |
| March 18, 2008 |
Sernova to Take Its First Regulatory Step Towards Clinical Trials - Granted Formal Pre-IND Meeting with FDA |
| March 17, 2008 |
Sernova Corp. Grants Stock Options |
| December 10, 2007 |
Successful Completion of Preclinical Sertolin Study: Regulatory Guidance Sought for Clinical Approval |
| September 24, 2007 |
FDA Consultant to Help Guide Sernova Through Regulatory Approval Process |
| September 10, 2007 |
Sertoli Cells Successfully Engineered to Secrete Insulin and are Effective in Preclinical Models of Diabetes |
| July 30, 2007 |
Sernova Files Worldwide Patent Application for Innovative Component of Diabetes |
| May 09, 2007 |
Sernova Raises $2.4 Million to Advance Sertolin to Clinical Trails |
| May 03, 2007 |
Sernova Directors and Management Established for 2007/2008 -- Dr. George Adams Named Chair; Justin Leushner Becomes CEO |
| April 16, 2007 |
Journal of Clinical Immunology: Sertoli Cells Could Replace Immunosuppressive Drugs in Humans |
| April 02, 2007 |
Sernova Corp. Information To Be Available Through S&P Market Access Program |
| February 05, 2007 |
Pre-Clinical Milestones for Sertolin Cell Replacement Technology: Insulin-Producing Cells Survive and Function without Anti-Rejection Drugs |
| January 08, 2007 |
Award Winning Harvard Diabetes Specialist Appointed to Help Advance Sernova's Sertolin Diabetes Therapy to Clinical Trials |
| December 19, 2006 |
Results of Toronto Hospital Study of Diabetic Mice Supports Sernova Corp's Cellular Therapy Technology |
| December 04, 2006 |
Leading Virologist Dr. Clive Patience Appointed to Help Guide the Development of Sernova's Proposed Diabetes Product |
| December 01, 2006 |
Breakthrough Magnetic Resonance Imaging Technique Developed for Diabetes's Cellular Therapy: Published in November Issue of Medical Journal, "Diabetes" |
| October 23, 2006 |
Sernova's Research Following Latest NIH Guidelines for Type 1 Diabetes |
| October 02, 2006 |
Sernova's Sertoli Cell Research Hopes to Replace Anti-Rejection Drugs in Edmonton Protocol Islet Transplants for Diabetics |
| September 25, 2006 |
Dr. George Adams Appointed to Board of Directors to Help Commercialize Insulin Dependent Diabetes Product |
| September 20, 2006 |
Diabetic Product Development Leads to Name Change: Sernova Corp. |
| August 01, 2006 |
Pheromone Builds Scientific Advisory Board: Sertoli Cell Expert Dr. Jannette Dufour to Help Develop Diabetes Product |
| July 28, 2006 |
Business Advisory Board Established to Commercialize Diabetes Product |
| July 25, 2006 |
Pheromone's Principal Researcher to Present 'Diabetes Reversal Model' at World Transplant Congress |
| July 19, 2006 |
Pheromone Builds Scientific Advisory Board: Appoints Dr. Norman Wong to Help Develop Diabetes Product |
| July 10, 2006 |
Charles Allard Appointed to Board of Directors |
| June 26, 2006 |
Justin Leushner Appointed to Board of Directors |
| June 19, 2006 |
Dr. David White to Become Principal Researcher and Chair of Scientific Advisory Board |
| May 25, 2006 |
Pheromone Receives TSX Approval of Joint Venture and Completes $3.2 Million Financing |
| April 03, 2006 |
Pheromone Sciences Increases Private Placement |
| March 20, 2006 |
Pheromone Issues Stock Options |
| March 20, 2006 |
Pheromone Sciences Signs Joint Venture Agreement for New Research Project |
| October 11, 2005 |
Pheromone Sciences to Finance and Acquire Sertonex/Sertoli Technologies |
| June 08, 2005 |
Pheromone Sciences Appoints New CFO |
| March 28, 2005 |
Pheromone Sciences Corp Announces Appointment of Mr. Dev Randhawa, MBA, as President and CEO & Director. |
| March 14, 2005 |
*Pheromone Sciences Corp Announces USA Launch of Fertility Monitor |
| October 12, 2004 |
Pheromone Sciences Retains AGORA Investor Relations |
| September 01, 2004 |
Asset Sale of Fertility Monitor Closes; HealthWatchSystems, Inc. Now Owns Product Outright |
| June 28, 2004 |
Pheromone Sciences' Fertility Monitor Commercial Order Issued |
| May 05, 2004 |
Pheromone Sciences Sells Worldwide Marketing Rights To Its Fertilité-OV(tm) Fertility Monitor Technology |
| February 20, 2004 |
Pheromone Sciences Corp Announces CFO Change |
| February 05, 2004 |
Pheromone Sciences Corp Announces Private Placement of Convertible Debentures. |
| January 29, 2004 |
Pheromone Sciences Corp Provides Update |
| December 16, 2003 |
Pheromone Sciences Corp. Announces that Rights Offering Does Not Hit Minimum Levels |
| November 10, 2003 |
Pheromone Sciences Corp Announces Rights Offering |
| August 11, 2003 |
Pheromone Successfully Completes Dairy Cow Fertility Monitoring Study |
| August 05, 2003 |
Pheromone Sciences Signs Chinese Distribution Agreement |
| July 23, 2003 |
Pheromone Sciences Issued U.S. Patent on Pheromone's Sensing and Reporting Technology |
| February 25, 2003 |
Pheromone Sciences Enters Advanced Dairy Testing |
| January 14, 2003 |
Pheromone Sciences Appoints Jim Wooder to Board of Directors |
| January 07, 2003 |
Pheromone Sciences Corp. Completes Private Placement Offering |
| October 29, 2002 |
PSC Fertility Monitor Success Story Profile The First In A Series |
| September 25, 2002 |
FDA Approves Pheromone Sciences' PSC Fertility Monitor |
| August 16, 2002 |
Pheromone Sciences Corp. Completes Private Placement Offering |
| June 17, 2002 |
UK's Largest Healthcare Retailer to Distribute Pheromone's Fertility Monitor |
| June 11, 2002 |
Pheromone Sciences' Successfully Completes Dairy Cow Monitoring Study |
| March 13, 2002 |
Pheromone Sciences Files with FDA for Marketing Approval of its Fertility Monitor |
| February 28, 2002 |
Pheromone Sciences Corp. Announces Annual and Special Meeting |
| February 12, 2002 |
Pheromone Sciences Corp Reports Positive Trial Results on Fertility Monitor |
| January 15, 2002 |
Pheromone Sciences Corp. Completes Private Placement Offering |
| November 27, 2001 |
Pheromone Sciences Corp. On Track and Moving Forward |
| November 05, 2001 |
Pheromone Sciences' PSC Fertility Monitor(TM) U.S. Trial Reaches Full Enrollment |
| October 15, 2001 |
Pheromone Sciences Corp. Receives European Regulatory Approval |
| September 04, 2001 |
Pamela Wallin Appointed to Pheromone Sciences Board of Directors |
| July 05, 2001 |
Pheromone Sciences Corp. Seeks European Regulatory Approval |
| June 18, 2001 |
Positive Clinical Trial Results Presented at the Society of OB/GYN Meeting. |
| June 05, 2001 |
Pheromone Sciences appoints Chief Financial Officer |
| May 22, 2001 |
Pheromone Sciences Pivotal Trial Patient Recruitment Underway Results Expected During Q-4 |
| April 12, 2001 |
Pheromone Sciences Corp. Receives Final Clearance on Prospectus |
| April 10, 2001 |
Pheromone Sciences Corp Receives Approval for U.S. Pivotal Trial |
| March 13, 2001 |
Pheromone Sciences Initiates Veterinary Program |
| March 05, 2001 |
Pheromone Sciences Corp's President and CEO, Christopher Neuman, Featured on ROB TV |
| February 26, 2001 |
Pheromone Sciences Corp. Completes Private Placement |
| February 15, 2001 |
Eldon Smith MD Appointed to Pheromone Sciences Board of Directors |
| February 14, 2001 |
Pheromone Sciences Corp Adds Half Warrant To Offering |
| February 13, 2001 |
Benoit La Salle Joins Pheromone Sciences Board of Directors |
| February 08, 2001 |
Pheromone Sciences Corp Announces U.S. Clinical Trials |
| January 22, 2001 |
Pheromone Sciences Corp. Announces Private Placement Offering |
| January 17, 2001 |
Pheromone Sciences Corp Announces Positive Clinical Trial Results |
| August 09, 2000 |
Pheromone Sciences Gains Marketing Approval from Therapeutic Products Programme of Health Canada for PSC Fertility Monitor(tm) |
| May 08, 2000 |
Pheromone Sciences appoints new CEO and CFO |
| May 02, 2000 |
Pheromone Sciences Announces Research & Development Status |
| February 28, 2000 |
Pheromone Sciences Corp. & Mecca Medi-Tech Complete Qualifying Transaction |
| January 26, 2000 |
Private Placement |
| October 20, 1999 |
Agreement Entered |
